Resonance Health Balance Sheet Health
Financial Health criteria checks 5/6
Resonance Health has a total shareholder equity of A$10.0M and total debt of A$3.0M, which brings its debt-to-equity ratio to 30%. Its total assets and total liabilities are A$17.9M and A$7.9M respectively.
Key information
30.0%
Debt to equity ratio
AU$3.01m
Debt
| Interest coverage ratio | n/a |
| Cash | AU$3.51m |
| Equity | AU$10.04m |
| Total liabilities | AU$7.90m |
| Total assets | AU$17.94m |
Recent financial health updates
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow
Mar 12
Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans
Aug 19Recent updates
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow
Mar 12Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans
Aug 19Are Robust Financials Driving The Recent Rally In Resonance Health Limited's (ASX:RHT) Stock?
Mar 01If You Had Bought Resonance Health (ASX:RHT) Stock Three Years Ago, You Could Pocket A 855% Gain Today
Jan 15How Does Resonance Health's (ASX:RHT) CEO Salary Compare to Peers?
Nov 22Financial Position Analysis
Short Term Liabilities: RHT's short term assets (A$7.0M) exceed its short term liabilities (A$4.8M).
Long Term Liabilities: RHT's short term assets (A$7.0M) exceed its long term liabilities (A$3.1M).
Debt to Equity History and Analysis
Debt Level: RHT has more cash than its total debt.
Reducing Debt: RHT's debt to equity ratio has increased from 0% to 30% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable RHT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: RHT is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 17.7% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/13 04:15 |
| End of Day Share Price | 2025/03/13 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Resonance Health Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.